Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prevalence of Hepatitis B Surface Antigen Among Hemodialysis Patients From Middle Eastern Countries: A Systematic Review and Meta-Analysis Publisher



Tavakoli A1, 2 ; Moghoofei M3, 4 ; Mostafaei S5, 6 ; Ghaffari H2 ; Monavari SH2 ; Alavian SM1, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, Iran
  2. 2. Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Microbiology, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
  4. 4. Studs Research Committee, Iran University of Medical Sciences, Tehran, Iran
  5. 5. Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
  7. 7. Middle East Liver Disease (MELD) Center, Tehran, Iran

Source: Future Virology Published:2017


Abstract

Aim: The aim of this study was to determine the overall prevalence of hepatitis B surface antigen (HBsAg) among hemodialysis patients reported from the Eastern Mediterranean Regional Office of the WHO (EMRO) countries and the Middle East. Methods: Several databases such as PubMed, ISI Web of Science, MEDLINE and Scopus were searched for publications reporting HBsAg prevalence among hemodialysis patients up to December 2016. Results: From all the samples, the pooled prevalence of HBsAg was estimated (95% CI) to be 4.4% (4.4-4.5%). Conclusion: The prevalence of HBsAg in hemodialysis units in the Middle Eastern countries is decreasing over the recent years. Nevertheless, it is important to conduct more studies in these regions to achieve more representative results. © 2017 Future Medicine Ltd.